Some relief at St. Jude

WASHINGTON - The families of children who participated in a gene therapy trial at St. Jude Children's Research Hospital learned last week that the gene therapy product used in an experiment was not contaminated with HIV or hepatitis C.

Laura Bowman, the principal investigator in the trial, told BioCentury that FDA testing determined that the vaccine used in the study was not contaminated.

Read the full 628 word article

How to gain access

Continue reading with a
two-week free trial.